Global Children Long-Acting Growth Hormone Market Growth 2025-2031
Description
The global Children Long-Acting Growth Hormone market size is predicted to grow from US$ 10180 million in 2025 to US$ 14880 million in 2031; it is expected to grow at a CAGR of 6.5% from 2025 to 2031.
According to World Bank statistics, the global birth rate in 2021 was about 1.7%. Although the population growth rate had slowed down, with the development of the world economy and the increase of per capita disposable income of residents, the spending power is growing. Therefore, there is still a large room for development in the baby products industry. Improving product quality and tapping the value of a single customer will become the drivers for the growth of the infant and child industry. Refinement and diversification are the core characteristics of the consumer demand. China has a large population base, and even if the population growth rate slows down, there will still be a demographic dividend. The State Council in 2022 proposes to "Guide market players to produce safer and healthier domestic infant products". According to the National Bureau of Statistics, China"s birth rate in 2022 was 6.77%, and the birth population was 9.56 million. According to the results of the seventh national census in 2021, the number of infants and young children aged 0-6 in China reached 140 million, of which the number of infants and young children aged 3-6 exceeded 70 million. The huge population size has brewed a market demand with huge potential, and the children"s consumption market has risen rapidly. Chinese families spend a lot on childcare, with the average cost of childcare ranking second in the world. The survey data released by China Research Center for Children"s Industry shows that in 80% of families in China, children"s expenditures account for 30% to 50% of household expenditures, and the average annual consumption of children in families is ¥17,000 to 25,500. According to data from the Yuwa Population Research, the national average cost of raising a child (the cost of raising a child to the age of 18) is ¥485,218. From the perspective of specific stages, the largest proportion is the cost of raising children aged 6-14, accounting for about 45%. The cost during pregnancy, the cost of childbirth and confinement, and the cost of raising babies aged 0-2 accounted for 2.06%, 2.09% and 13.33% separately.
LP Information, Inc. (LPI) ' newest research report, the “Children Long-Acting Growth Hormone Industry Forecast” looks at past sales and reviews total world Children Long-Acting Growth Hormone sales in 2024, providing a comprehensive analysis by region and market sector of projected Children Long-Acting Growth Hormone sales for 2025 through 2031. With Children Long-Acting Growth Hormone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Children Long-Acting Growth Hormone industry.
This Insight Report provides a comprehensive analysis of the global Children Long-Acting Growth Hormone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Children Long-Acting Growth Hormone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Children Long-Acting Growth Hormone market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Children Long-Acting Growth Hormone and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Children Long-Acting Growth Hormone.
This report presents a comprehensive overview, market shares, and growth opportunities of Children Long-Acting Growth Hormone market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Powder
Solvent
Segmentation by Application:
Growth Hormone Deficiency (GHD)
Turner Syndrome
Chronic Renal Insufficiency
Prader Willi Syndrome
Small for Gestational Age(SGA)
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Pfizer
Novo Nordisk
Eli Lilly
Merck Serono
F. Hoffmann-La Roche
Ferring Pharmaceuticals
Ipsen
LG Life Sciences
Sandoz International
Anhui Anke Biotechnology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Children Long-Acting Growth Hormone market?
What factors are driving Children Long-Acting Growth Hormone market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Children Long-Acting Growth Hormone market opportunities vary by end market size?
How does Children Long-Acting Growth Hormone break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
According to World Bank statistics, the global birth rate in 2021 was about 1.7%. Although the population growth rate had slowed down, with the development of the world economy and the increase of per capita disposable income of residents, the spending power is growing. Therefore, there is still a large room for development in the baby products industry. Improving product quality and tapping the value of a single customer will become the drivers for the growth of the infant and child industry. Refinement and diversification are the core characteristics of the consumer demand. China has a large population base, and even if the population growth rate slows down, there will still be a demographic dividend. The State Council in 2022 proposes to "Guide market players to produce safer and healthier domestic infant products". According to the National Bureau of Statistics, China"s birth rate in 2022 was 6.77%, and the birth population was 9.56 million. According to the results of the seventh national census in 2021, the number of infants and young children aged 0-6 in China reached 140 million, of which the number of infants and young children aged 3-6 exceeded 70 million. The huge population size has brewed a market demand with huge potential, and the children"s consumption market has risen rapidly. Chinese families spend a lot on childcare, with the average cost of childcare ranking second in the world. The survey data released by China Research Center for Children"s Industry shows that in 80% of families in China, children"s expenditures account for 30% to 50% of household expenditures, and the average annual consumption of children in families is ¥17,000 to 25,500. According to data from the Yuwa Population Research, the national average cost of raising a child (the cost of raising a child to the age of 18) is ¥485,218. From the perspective of specific stages, the largest proportion is the cost of raising children aged 6-14, accounting for about 45%. The cost during pregnancy, the cost of childbirth and confinement, and the cost of raising babies aged 0-2 accounted for 2.06%, 2.09% and 13.33% separately.
LP Information, Inc. (LPI) ' newest research report, the “Children Long-Acting Growth Hormone Industry Forecast” looks at past sales and reviews total world Children Long-Acting Growth Hormone sales in 2024, providing a comprehensive analysis by region and market sector of projected Children Long-Acting Growth Hormone sales for 2025 through 2031. With Children Long-Acting Growth Hormone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Children Long-Acting Growth Hormone industry.
This Insight Report provides a comprehensive analysis of the global Children Long-Acting Growth Hormone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Children Long-Acting Growth Hormone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Children Long-Acting Growth Hormone market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Children Long-Acting Growth Hormone and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Children Long-Acting Growth Hormone.
This report presents a comprehensive overview, market shares, and growth opportunities of Children Long-Acting Growth Hormone market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Powder
Solvent
Segmentation by Application:
Growth Hormone Deficiency (GHD)
Turner Syndrome
Chronic Renal Insufficiency
Prader Willi Syndrome
Small for Gestational Age(SGA)
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Pfizer
Novo Nordisk
Eli Lilly
Merck Serono
F. Hoffmann-La Roche
Ferring Pharmaceuticals
Ipsen
LG Life Sciences
Sandoz International
Anhui Anke Biotechnology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Children Long-Acting Growth Hormone market?
What factors are driving Children Long-Acting Growth Hormone market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Children Long-Acting Growth Hormone market opportunities vary by end market size?
How does Children Long-Acting Growth Hormone break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
101 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Children Long-Acting Growth Hormone by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Children Long-Acting Growth Hormone by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
